Genome-wide association studies in multiple sclerosis: Lessons and future prospects

Briefings in Functional Genomics

Volumn 10, Issue 2, 2011, Pages 61-70

  Kemppinen, Anu ^a   Sawcer, Stephen ^a   Compston, Alastair ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

Autoimmune disease; Genome wide association; Multiple sclerosis

Indexed keywords

AMINO ACID SUBSTITUTION; ARTICLE; AUTOIMMUNE DISEASE; AUTOIMMUNITY; CD4+ T LYMPHOCYTE; GENE EXPRESSION; GENE FREQUENCY; GENE FUNCTION; GENE LOCUS; GENETIC ASSOCIATION; GENETIC RISK; GENETIC VARIABILITY; HAPLOTYPE; HUMAN; MULTIPLE SCLEROSIS; SINGLE NUCLEOTIDE POLYMORPHISM;

AUTOIMMUNITY; GENETIC PREDISPOSITION TO DISEASE; GENETIC VARIATION; GENOME-WIDE ASSOCIATION STUDY; HUMANS; MULTIPLE SCLEROSIS; NEURONS;

EID: 79954545784     PISSN: 20412649     EISSN: None     Source Type: Journal    
DOI: 10.1093/bfgp/elr004     Document Type: Article

References (69)

1. Compston A, Coles A. Multiple sclerosis. Lancet 2008;372: 1502-17.
2. Hawkes CH, Macgregor AJ. Twin studies and the heritability of MS: a conclusion. Mult Scler 2009;15:661-7.
3. Lauer K. Environmental risk factors in multiple sclerosis. Expert Rev Neurother 2010;10:421-40.
4. Jersild C, Fog T, Hansen GS, et al. Histocompatibility determinants in multiple sclerosis, with special reference to clinical course. Lancet 1973;2:1221-5.
5. Jersild C, Svejgaard A, Fog T. HL-A antigens and multiple sclerosis. Lancet 1972;1:1240-1.
6. Naito S, Namerow N, Mickey MR, et al. Multiple sclerosis: association with HL-A3. TissueAntigens 1972;2:1-4.
7. International Multiple Sclerosis Genetics Consortium, Hafler DA, Compston A, et al. Risk alleles for multiple sclerosis identified by a genomewide study. N Engl J Med 2007;357:851-62.
8. Sawcer S. The complex genetics of multiple sclerosis: pitfalls and prospects. Brain 2008;131:3118-31.
9. Australia and New Zealand Multiple Sclerosis Genetics Consortium (ANZgene) Genome-wide association study identifies new multiple sclerosis susceptibility loci on chromosomes 12 and 20. Nat Genet 2009;41:824-8.
10. Aulchenko YS, Hoppenbrouwers IA, Ramagopalan SV, et al. Genetic variation in the KIF1B locus influences susceptibility to multiple sclerosis. Nat Genet 2008;40:1402-3.
11. Baranzini SE, Wang J, Gibson RA, et al. Genomewide association analysis of susceptibility and clinical phenotype in multiple sclerosis. Hum Mol Genet 2009;18: 767-78.
12. Comabella M, Craig DW, Camiña-Tato M, et al. Identification of a novel risk locus for multiple sclerosis at 13q31.3 by a pooled genome-wide scan of 500,000 single nucleotide polymorphisms. PLoS One 2008;3:e3490.
13. De Jager PL, Jia X, Wang J, et al. Meta-analysis of genome scans and replication identify CD6, IRF8 and TNFRSF1A as new multiple sclerosis susceptibility loci. Nat Genet 2009; 41:776-82.
14. Jakkula E, Leppä V, Sulonen AM, et al. Genome-wide association study in a high-risk isolate for multiple sclerosis reveals associated variants in STAT3 gene. Am J Hum Genet 2010;86:285-91.
15. Nischwitz S, Cepok S, Kroner A, et al. Evidence for VAV2 and ZNF433 as susceptibility genes for multiple sclerosis. J Neuroimmunol 2010;227:162-6.
16. Sanna S, Pitzalis M, Zoledziewska M, et al. Variants within the immunoregulatory CBLB gene are associated with multiple sclerosis. Nat Genet 2010;42:495-7.
17. Wellcome Trust Case Control Consortium; Australo-Anglo-American Spondylitis Consortium (TASC), Burton PR, et al. Association scan of 14,500 nonsynonymous SNPs in four diseases identifies autoimmunity variants. Nat Genet 2007;39:1329-37.
18. Lundmark F, Duvefelt K, Iacobaeus E, et al. Variation in interleukin 7 receptor alpha chain (IL7R) influences risk of multiple sclerosis. Nat Genet 2007;39:1108-13.
19. Gregory SG, Schmidt S, Seth P, et al. Interleukin 7 receptor alpha chain (IL7R) shows allelic and functional association with multiple sclerosis. Nat Genet 2007;39:1083-91.
20. International Multiple Sclerosis Genetics Consortium (IMSGC). Refining genetic associations in multiple sclerosis. Lancet Neurol 2008;7:567-9.
21. De Jager PL, Baecher-Allan C, Maier LM, et al. The role of the CD58 locus in multiple sclerosis. Proc Natl Acad Sci USA 2009;106:5264-9.
22. Hoppenbrouwers IA, Aulchenko YS, Janssens AC, et al. Replication of CD58 and CLEC16A as genome-wide significant risk genes for multiple sclerosis. J Hum Genet 2009; 54:676-80.
23. International Multiple Sclerosis Genetics Consortium (IMSGC). The expanding genetic overlap between multiple sclerosis and type I diabetes. Genes Immun 2009;10:11-4.
24. International Multiple Sclerosis Genetics Consortium (IMSGC). Comprehensive follow-up of the first genomewide association study of multiple sclerosis identifies KIF21B and TMEM39A as susceptibility loci. Hum Mol Genet 2010;19:953-62.
25. Ban M, Goris A, Lorentzen AR, et al. Replication analysis identifies TYK2 as a multiple sclerosis susceptibility factor. Eur J Hum Genet 2009;17:1309-13.
26. Mero IL, Lorentzen AR, Ban M, et al. A rare variant of the TYK2 gene is confirmed to be associated with multiple sclerosis. Eur J Hum Genet 2010;18:502-4.
27. Ban M, McCauley JL, Zuvich R, et al. A non-synonymous SNP within membrane met alloendopeptidase-like 1 (MMEL1) is associated with multiple sclerosis. Genes Immun 2010;11:660-4.
28. International Multiple Sclerosis Genetics Consortium (IMSGC). IL12A, MPHOSPH9/CDK2AP1 and RGS1 are novel multiple sclerosis susceptibility loci. Genes Immun 2010;11:397-405.
29. International Multiple Sclerosis Genetics Consortium (IMSGC), Booth DR, Heard RN, et al. Lack of support for association between the KIF1B rs10492972[C] variant and multiple sclerosis. Nat Genet 2010;42:469-70.
30. Dubois PC, Trynka G, Franke L, et al. Multiple common variants for celiac disease influencing immune gene expression. Nat Genet 2010;42:295-302.
31. Gandhi KS, McKay FC, Cox M, et al. The multiple sclerosis whole blood mRNA transcriptome and genetic associations indicate dysregulation of specific T cell pathways in pathogenesis. Hum Mol Genet 2010;19:2134-43.
32. Handel AE, Handunnetthi L, Berlanga AJ, et al. The effect of single nucleotide polymorphisms from genome wide association studies in multiple sclerosis on gene expression. PLoS One 2010;5:e10142.
33. + T helper cell differentiation and inflammatory diseases. Cytokine 2009;47:149-56.
34. Dixon AL, Liang L, Moffatt MF, et al. A whole-genome association study of global gene expression. Nat Genet 2007; 39:1202-7.
35. Moffatt MF, Kabesch M, Liang L, et al. Genetic variants regulating ORMDL3 expression are determinants of susceptibility to childhood asthma. Nature 2007;448:470-3.
36. Bachmaier K, Krawczyk C, Kozieradzki I, et al. Negative regulation of lymphocyte activation and autoimmunity by the molecular adaptor Cbl-b. Nature 2000;403:211-6.
37. Swack JA, Gangemi RM, Rudd CE, et al. Structural characterization of CD6: properties of two distinct epitopes involved in T cell activation. Mol Immunol 1989;26: 1037-49.
38. Hughes CC, Savage CO, Pober JS. Endothelial cells augment T cell interleukin 2 production by a contact-dependent mechanism involving CD2/LFA-3 interaction. J Exp Med 1990;171:1453-67.
39. Dardalhon V, Schubart AS, Reddy J, et al. CD226 is specifically expressed on the surface of Th1 cells and regulates their expansion and effector functions. J Immunol 2005;175: 1558-65.
40. Huang X, Li Y, Tanaka K, et al. Cloning and characterization of Lnk, a signal transduction protein that links T-cell receptor activation signal to phospholipase C gamma 1, Grb2, and phosphatidylinositol 3-kinase. Proc Natl Acad Sci USA 1995;92:11618-22.
41. Düwel M, Welteke V, Oeckinghaus A, et al. A20 negatively regulates T cell receptor signaling to NF-kappaB by cleaving Malt1 ubiquitin chains. J Immunol 2009;182:7718-28.
42. Fry TJ, Mackall CL. Interleukin-7: master regulator of peripheral T-cell homeostasis? Trends Immunol 2001;22: 564-71.
43. Marszalek JR, Weiner JA, Farlow SJ, et al. Novel dendritic kinesin sorting identified by different process targeting of two related kinesins: KIF21A and KIF21B. J Cell Biol 1999;145:469-79.
44. UK IBD Genetics Consortium, Barrett JC, Lee JC, et al. Genome-wide association study of ulcerative colitis identifies three new susceptibility loci, including the HNF4A region. Nat Genet 2009;41:1330-4.
45. International Multiple Sclerosis Genetics Consortium (IMSGC), Bush WS, Sawcer SJ, et al. Evidence for polygenic susceptibility to multiple sclerosis-the shape of things to come. Am J Hum Genet 2010;86:621-5.
46. Baranzini SE, Galwey NW, Wang J, et al. Pathway and network-based analysis of genome-wide association studies in multiple sclerosis. Hum Mol Genet 2009;18: 2078-90.
47. Vereecke L, Beyaert R, van Loo G. The ubiquitin-editing enzyme A20 (TNFAIP3) is a central regulator of immuno-pathology. Trends Immunol 2009;30(8):383-91.
48. Hayden MS, Ghosh S. Shared principles in NF-kappaB signaling. Cell 2008;132:344-62.
49. Kochi Y, Okada Y, Suzuki A, et al. A regulatory variant in CCR6 is associated with rheumatoid arthritis susceptibility. Nat Genet 2010;42:515-9.
50. Han JW, Zheng HF, Cui Y, et al. Genome-wide association study in a Chinese Han population identifies nine new susceptibility loci for systemic lupus erythematosus. Nat Genet 2009;41:1234-7.
51. Huang X, Li Y, Tanaka K, et al. Cloning and characterization of Lnk, a signal transduction protein that links T-cell receptor activation signal to phospholipase C gamma 1, Grb2, and phosphatidylinositol 3-kinase. Proc Natl Acad Sci USA 1995;92:11618-22.
52. Tong W, Zhang J, Lodish HF. Lnk inhibits erythropoiesis and Epo-dependent JAK2 activation and downstream signaling pathways. Blood 2005;105:4604-12.
53. Li X, Thyssen G, Beliakoff J, et al. The novel PIAS-like protein hZimp10 enhances Smad transcriptional activity. J Biol Chem 2006;281:23748-56.
54. Giliani S, Bonfim C, de Saint Basile G, et al. Omenn syndrome in an infant with IL7RA gene mutation. J Pediatr 2006;148:272-4.
55. Puel A, Ziegler SF, Buckley RH, et al. Defective IL7R expression in T(-)B(+)NK(+) severe combined immunodeficiency. Nat Genet 1998;20:394-7.
56. Roifman CM, Zhang J, Chitayat D, et al. A partial deficiency of interleukin-7R-alpha is sufficient to abrogate T-cell development and cause severe combined immunodeficiency. Blood 2000;96:2803-7.
57. McDermott MF, Aksentijevich I, Galon J, et al. Germline mutations in the extracellular domains of the 55 kDa TNF receptor, TNFR1, define a family of dominantly inherited autoinflammatory syndromes. Cell 1999;97:133-44.
58. Holland SM, DeLeo FR, Elloumi HZ, et al. STAT3 mutations in the hyper-IgE syndrome. N Engl J Med. 2007;357: 1608-19.
59. Minegishi Y, Saito M, Morio T, et al. Human tyrosine kinase 2 deficiency reveals its requisite roles in multiple cytokine signals involved in innate and acquired immunity. Immunity 2006;25:745-55.
60. Renner ED, Torgerson TR, Rylaarsdam S, et al. STAT3 mutation in the original patient with Job's syndrome. N Engl J Med 2007;357:1667-8.
61. Minegishi Y, Saito M, Tsuchiya S, et al. Dominant-negative mutations in the DNA-binding domain of STAT3 cause hyper-IgE syndrome. Nature 2007;448:1058-62.
62. Wan J, Fu AK, Ip FC, et al. Tyk2/STAT3 signaling mediates beta-amyloid-induced neuronal cell death: implications in Alzheimer's disease. J Neurosci 2010;30:6873-81.
63. Dickson SP, Wang K, Krantz I, et al. Rare variants create synthetic genome-wide associations. PLoS Biol 2010;8: e1000294.
64. Cirulli ET, Goldstein DB. Uncovering the roles of rare variants in common disease through whole-genome sequencing. Nat Rev Genet 2010;11:415-25.
65. Nejentsev S, Walker N, Riches D, et al. Rare variants of IFIH1, a gene implicated in antiviral responses, protect against type 1 diabetes. Science 2009;324:387-9.
66. Surolia I, Pirnie SP, Chellappa V, et al. Functionally defective germline variants of sialic acid acetylesterase in autoimmunity. Nature 2010;466:243-7.
67. Baranzini SE, Mudge J, van Velkinburgh JC, et al. Genome, epigenome and RNA sequences of monozygotic twins discordant for multiple sclerosis. Nature 2010;464: 1351-6.
68. Johnson BA, Wang J, Taylor EM, et al. Multiple sclerosis susceptibility alleles in African Americans. Genes Immun 2010;11:343-50.
69. Pandit L, Ban M, Sawcer S, et al. Evaluation of the established non-MHC multiple sclerosis loci in an Indian population. Mult Scler. In press.